News

Health Secretary Robert F. Kennedy Jr. announced a slate of eight new members to serve on the Advisory Committee on Immunization Practices, which advises the Centers for Disease Control and Prevention ...
The U.S. Food and Drug Administration has approved Moderna’s (MRNA) RSV vaccine, mRESVIA (mRNA-1345), for preventing lower respiratory tract disease in adults aged 18 to 59 who are at higher risk for ...
Zepto's promise of convenience has been shattered by the reality of potential health hazards and regulatory failures. Until ...
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and ...
In late May 2025, a New York Times article detailed a supposed combined effort between the U.S. federal government and the data analysis software company Palantir to centralize da ...
HHS Secretary Robert F. Kennedy Jr. selected eight new members for the Advisory Committee on Immunization Practices.
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.
Thousands of cases of a fan-favorite ice cream have been classified as a class two recall, according to the Food and Drug Administration.
Texas Governor Greg Abbott signed Senate Bill 2308, promoting ibogaine research for treating opioid addiction, depression, ...
Moderna said the Food and Drug Administration expanded its approval of the pharmaceutical company's respiratory syncytial virus vaccine, mResvia, to adults aged 18-59 at increased risk for the disease ...